# US 2024/0188835 A1 · System and method for non-invasive assessment of cardiovascular and pulmonary murmurs

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0188835 A1
- Document ID: US20240188835A1
- Status: Published application
- Kind: A1
- Application number: 18/444,684
- Filed: 2024-02-17
- Published: 2024-06-13
- Earliest claimed: 2017-01-03
- Assignees: AventuSoft, LLC
- Applicants: AventuSoft, LLC
- Inventors: Claudia Iannini; Kaustubh Kale
- Web page: https://patentgrep.com/patent/US20240188835A1

## CPC

- A61B 5/0006: {ECG or EEG signals}
- A61B 5/0205: Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
- A61B 5/02007: {Evaluating blood vessel condition, e.g. elasticity, compliance}
- A61B 5/02108: {from analysis of pulse wave characteristics}
- A61B 5/0816: {Measuring devices for examining respiratory frequency (measuring frequency of electric signals G01R23/00)}
- A61B 5/1102: {Ballistocardiography}
- A61B 5/1455: using optical sensors, e.g. spectral photometrical oximeters
- A61B 5/332: Portable devices specially adapted therefor
- A61B 5/361: Detecting fibrillation
- A61B 5/6833: {Adhesive patches}
- A61B 5/7221: {Determining signal validity, reliability or quality (preventing, reducing or removing noise induced by motion artefacts A61B5/7207; noise originating from a therapeutic or surgical apparatus A61B5/7217)}
- A61B 5/7275: {Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor}
- A61B 7/00: Instruments for auscultation
- A61B 7/04: Electric stethoscopes
- A61B 5/02028: {Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction}
- A61B 5/08: Measuring devices for evaluating the respiratory organs
- A61B 5/7282: {Event detection, e.g. detecting unique waveforms indicative of a medical condition (cough events A61B5/0823; seizures A61B5/4094; sleep apnoea A61B5/4818)}
- A61B 2562/0204: Acoustic sensors
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A method or system for noninvasive evaluating and monitoring of abnormal cardiopulmonary vibrations includes obtaining one or more signals using one or more noninvasive heart and/or lung vibration signal sensors or transducers that provide a measure of physiological effects that are correlated with cardiopulmonary functions, recording, by a processor and one or more heart and/or lung vibration signal sensors or transducers for turbulence recordings between a first and second cardiopulmonary sounds, analyzing the turbulence recordings for unique vibration signatures associated with cardiopulmonary disease by searching deviations from an average beat, and presenting an assessment of cardiopulmonary disease upon finding that the deviations are above a predetermined threshold. In some embodiments, the system and method further include seeking a largest mean absolute error of a specific segment between an average beat and each beat from a subject to provide a murmur level indicative of cardiopulmonary disease.

## Claims

### Claim 1

A method for noninvasive evaluating and monitoring of abnormal cardiovascular or pulmonary vibrations based on quantitative measurements of cardiovascular or pulmonary events for diagnostic and therapeutic purposes, comprising:
obtaining one or more signals using one or more noninvasive cardiopulmonary vibration signal sensors or transducers that provide a measure of one or more physiological effects that are correlated with cardiopulmonary functions;
recording, by at least one processor and the one or more cardiopulmonary vibration signal sensors or transducers for turbulence recordings;
analyzing the turbulence recordings for unique vibration signatures associated with cardiopulmonary disease by searching for one or more deviations from an average beat; and
presenting an assessment of cardiopulmonary disease upon finding that the one or more deviations are above a predetermined threshold.

### Claim 2 (depends on 1)

The method of claim 1, wherein the method further comprises the step of seeking a largest mean absolute error of a specific segment between an average beat and each beat from a subject to provide a cardiopulmonary murmur level indicative of cardiopulmonary disease.

### Claim 3 (depends on 1)

The method of claim 1, wherein the one or more noninvasive cardiopulmonary vibration signal sensors or transducers are one or more noninvasive seismocardiography (SCG), GCG, PCG, BCG, vibration sensors or transducers.

### Claim 4 (depends on 1)

The method of claim 1, wherein a cardiovascular disease evaluated and monitored by the method is coronary artery disease (CAD).

### Claim 5 (depends on 1)

The method of claim 1, wherein a cardiopulmonary disease evaluated and monitored by the method is chronic obstructive pulmonary disease (COPD).

### Claim 6 (depends on 1)

The method of claim 1, wherein a valve disease or diseases evaluated and monitored is one or more murmurs, among aortic stenosis (AS), mitral regurgitation (MR), aortic regurgitation (AR), mitral stenosis (MS), or mitral valve prolapse (MVP).

### Claim 7 (depends on 1)

The method of claim 1, wherein the analyzing of the turbulence recordings occurs between a first heart sound and a second heart sound.

### Claim 8 (depends on 7)

The method of claim 7, wherein the first heart sound is S1 and the second heart sound is S2 or the first heart sound is S2 and the second heart sound is S3 or the first heart sound is S3 and the second heart sound is S4.

### Claim 9 (depends on 1)

The method of claim 1, wherein analyzing the turbulence recordings for unique vibration signatures associated with cardiopulmonary disease is done by searching for the one or more deviations from the average beat during a late systole segment or during a diastole segment.

### Claim 10

A system for noninvasive evaluating and monitoring of abnormal vibrations based on quantitative measurements of cardiovascular or pulmonary events for diagnostic and therapeutic purposes, comprising:
at least one or more non-invasive vibration signal sensors or transducers for capturing one or more waveform signals providing a measure of one or more physiological effects that are correlated with cardiopulmonary functions;
one or more processors operatively coupled to the at least one or more non-invasive vibration signal sensors or transducers;
memory having computer instructions and coupled to the one or more processors, the computer instructions which when executed by the one or more processors causes the system to perform the operations of:
obtaining one or more signals using the one or more noninvasive cardiopulmonary vibration signal sensors or transducers that provide the measure of one or more physiological effects that are correlated with cardiopulmonary functions;
recording, by the at least one or more processors and the one or more heart vibration signal sensors or transducers for turbulence recordings between a first cardiac sound and a second cardiac sound;
analyzing the turbulence recordings between the first cardiac sound and the second cardiac sound for unique vibration signatures associated with cardiopulmonary disease by searching for deviations from an average beat; and
presenting an assessment of the cardiovascular or pulmonary disease upon finding that the one or more deviations are above a predetermined threshold.

### Claim 11 (depends on 10)

The system of claim 10, wherein the system further comprises the step of seeking a largest mean absolute error of a specific segment between an average beat and each beat from a subject to provide a cardiopulmonary murmur level indicative of cardiopulmonary disease.

### Claim 12 (depends on 10)

The system of claim 10, wherein the one or more noninvasive cardiopulmonary vibration signal sensors or transducers comprise at least two sensors comprising one or more noninvasive sensors among an electrocardiogram (ECG) sensor, seismocardiography (SCG) sensor, a gyrocardiography (GCG) sensor, an impedance cardiography (ICG) sensor, a phonocardiophy (PCG) sensor, a photoplethysmogram (PPG) sensor, or a ballistocardiogram (BCG) sensor.

### Claim 13 (depends on 10)

The system of claim 10, wherein the abnormal vibrations evaluated and monitored is one among a number of pathological cardiopulmonary murmurs from vessels that supply blood to the heart that includes coronary artery disease (CAD).

### Claim 14 (depends on 10)

The system of claim 10, wherein the abnormal vibrations evaluated and monitored is chronic obstructive pulmonary disease (COPD).

### Claim 15 (depends on 10)

The system of claim 10, wherein the abnormal vibrations evaluated and monitored is one or more valvular disease murmurs, among aortic stenosis (AS), mitral regurgitation (MR), aortic regurgitation (AR), mitral stenosis (MS), or mitral valve prolapse (MVP).

### Claim 16 (depends on 10)

The system of claim 10, wherein the first cardiac sound is S1 and the second cardiac sound is S2 or the first cardiac sound is S2 and the second cardiac sound is S3.

### Claim 17 (depends on 10)

The system of claim 10, wherein the assessment of the cardiopulmonary disease provides an identification of the cardiac disease and a severity level of the identified cardiopulmonary disease.

### Claim 18 (depends on 10)

The system of claim 10, wherein analyzing the turbulence recordings between the first cardiac sound and the second cardiac sound for unique vibration signatures associated with cardiopulmonary disease is done by searching for the one or more deviations from the average beat during a late systole segment or during a late diastole segment.

### Claim 19

An apparatus for noninvasive evaluating and monitoring of cardiopulmonary disease based on quantitative measurements of cardiac events for diagnostic and therapeutic purposes, comprising:
at least two or more non-invasive vibration signal sensors or transducers for capturing one or more cardiac waveform signals providing a measure of one or more physiological effects that are correlated with cardiopulmonary functions using a heart murmur level measurement within a given segment;
one or more processors operatively coupled to the at least one or more non-invasive vibration signal sensors or transducers;
memory having computer instructions and coupled to the one or more processors, the computer instructions which when executed by the one or more processors causes the system to perform the operations of:
obtaining one or more signals using the one or more noninvasive heart vibration signal sensors or transducers that provide the measure of one or more physiological effects that are correlated with cardiopulmonary functions;
recording, by the at least one or more processors and the two or more heart vibration signal sensors or transducers for turbulence recordings between a first cardiac sound and a second cardiac sound;
analyzing the turbulence recordings between the first cardiac sound and the second cardiac sound for unique vibration signatures associated with cardiopulmonary disease by searching for deviations from an average beat; and
presenting an assessment of cardiopulmonary disease upon finding that the one or more deviations are beyond a predetermined threshold beyond a normal cardiopulmonary vibration.

### Claim 20 (depends on 19)

The apparatus of claim 19, wherein a first non-invasive vibration signal sensor is an accelerometer sensor (SCG, GCG, PCG, BCG) and wherein a second non-invasive vibration signal sensor or transducer is one among an electrocardiogram (ECG), seismocardiography (SCG) sensor, a gyrocardiography (GCG) sensor, an impedance cardiography (ICG) sensor, a phonocardiophy (PCG) sensor, a photoplethysmogram (PPG) sensor, or a ballistocardiogram (BCG) sensor.
